• The Pharma Fast 50

    PharmaTimes presents Alantra’s annual ranking of the fastest growing private pharma companies in the UK

  • Powerful progress

    Veeva’s predictions for the life sciences industry in 2021

  • Cash controllers

    Oli Hudson and Steve How, of Wilmington Healthcare, explore how NHS England’s new system-level funding works and the impact on prescribing for high cost drugs

News

View all

Web Exclusives

View all
Thumbnail image for A new focus

A new focus

Castleman disease (CD) is a rare and potentially life-threatening disease. Like so many rare diseases, it is often misdiagnosed, or goes undiagnosed. On Rare Disease Day, EUSA Pharma’s Jon Morgan, VP global head of Medical, discusses the need to bring a new focus to rare diseases like CD

Thumbnail image for A call to action

A call to action

If we want to beat COVID-19, vaccination must be an urgent global effort

Thumbnail image for Time for change

Time for change

Why governments need to rethink their regulatory framework in 2021

Thumbnail image for Smart People: Andrew Meade

Smart People: Andrew Meade

PharmaTimes talks to Andrew Meade, Accenture’s UK and Ireland Life Sciences lead, about the opportunities and challenges triggered by COVID-19 for medicine and digital tech

Thumbnail image for The missing piece of the puzzle

The missing piece of the puzzle

Supplementing disease modelling with microbiome data is set to enable the life sciences industry to understand more about how drugs interact with different people, and devise more targeted treatments. Anthony Finbow explains how the science of microbiomes will increasingly contribute to pharma research outcomes

Thumbnail image for Hidden impact

Hidden impact

The effect of the COVID-19 pandemic on lung cancer care, and learning lessons from across Europe

Thumbnail image for A global effort?

A global effort?

COVID-19 threw pharma’s performance on access to medicine into the spotlight. Has the industry passed the test?

Thumbnail image for Cash controllers

Cash controllers

Oli Hudson and Steve How, of Wilmington Healthcare, explore how NHS England’s new system-level funding works and the impact on prescribing for high cost drugs

Thought Leadership

View all

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download